Cleared Traditional

K130724 - CODIAGNOSTIX IMPLANT PLANNING SOFTWARE

K130724 is the FDA 510(k) clearance for CODIAGNOSTIX IMPLANT PLANNING SOFTWARE by Straumann USA. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 102-day FDA review.

K130724 · Straumann USA · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2013
Decision
102d
Days
Class 2
Risk

K130724 is an FDA 510(k) clearance for the CODIAGNOSTIX IMPLANT PLANNING SOFTWARE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Straumann USA (Andover, US). The FDA issued a Cleared decision on June 28, 2013 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Straumann USA devices

Submission Details

510(k) Number K130724 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 2013
Decision Date June 28, 2013
Days to Decision 102 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
5d faster than avg
Panel avg: 107d · This submission: 102d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1127
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K130724.
QLAB QUANTIFICATION SOFTWARE
K132165 · Philips Ultrasound, Inc. · Aug 2013
ULTRAEXTEND USWS-900A V2.1 AND V3.1
K131822 · Toshiba America Medical Systems, In.C · Jul 2013
ESIE APPS SUITE
K132062 · Siemens Medical Solutions USA, Inc. · Jul 2013
SYNAPSE 3D LUNG AND ABDOMEN ANALYSIS
K130542 · Fujifilm Medical System U.S.A., Inc. · Jun 2013
MR PERMEABILITY
K130278 · Philips Medical Systems Nederland B.V. · May 2013
NIO COLOR 3MP LED
K131295 · Barco N.V. · May 2013